GlassScriptPhysician profile
Brian M Friedman
NPI 1538115522
$5,206.95
in general payments reported to CMS, 2019-2025
34 companies · $681 in 2025
The $681 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $240 · 2021: $1,115 · 2022: $820 · 2023: $775 · 2024: $1,043 · 2025: $681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,466 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,465.88 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $522.23 | 2021-2025 | Pulseselect, Cobalt Dr Mri Surescan, Onyx Frontier |
| Abbott Laboratories | $430.76 | 2019-2024 | Pressurewire, Cardiomems, Mitraclip |
| Abiomed | $401.18 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $391.55 | 2021-2025 | Lifevest |
| Amgen INC. | $373.66 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $261.95 | 2020-2025 | Camzyos, Eliquis |
| Irhythm Technologies, INC. | $246.31 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $221.69 | 2020-2024 | Watchman Flx, Emerge Push |
| Novartis Pharmaceuticals Corporation | $218.89 | 2019-2025 | |
| Pfizer INC. | $196.98 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $196.25 | 2019-2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $186.68 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $185.46 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $175.79 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Livanova USA, INC. | $152.02 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $151.36 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $124.88 | 2023 | Xarelto |
| Terumo Medical Corporation | $119.74 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $103.98 | 2021-2025 | |
| Edwards Lifesciences Corporation | $75.71 | 2021-2024 | Sapien 3 Ultra Resilia |
| Alnylam Pharmaceuticals INC. | $66.75 | 2019-2024 | Onpattro |
| Lantheus Medical Imaging, INC. | $51.74 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $46.12 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $44.37 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $41.67 | 2023-2024 | Evkeeza |
| Bayer Healthcare Pharmaceuticals INC. | $31.89 | 2021-2025 | |
| Genzyme Corporation | $31.43 | 2025 | |
| Merck Sharp & Dohme LLC | $30.28 | 2021-2022 | |
| Recor Medical INC | $29.38 | 2025 | Paradise Ultrasound Renal Denervation System |
| Penumbra, INC. | $24.65 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $24.58 | 2023 | Arcalyst |
| Esperion Therapeutics, INC. | $16.70 | 2021 | |
| Teleflex LLC | $16.25 | 2020 | |
| Philips North America LLC | $14.07 | 2025 | Neoview |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.